NHS Commits to Reevaluating Cross-Sex Hormone Prescriptions
The long-term use of drugs has been linked to osteoporosis and Alzheimer’s disease, with irreversible effects on physical appearance and voice.
NHS England has promised to review the prescription of cross-sex hormones for over-16s in response to a critical report on the services for children and young people with “gender identity” issues.
While the prescription of puberty blockers for children under 16 has already been banned by the health service, the prescribing of feminising and masculinising drugs for young people aged 16–25 and older adults is still ongoing.
The use of cross-sex hormones can lead to various health problems, infertility, and irreversible physical changes, leaving individuals who change their minds about their gender identity with lasting regret.
Known side effects of testosterone-blocking drugs include increased risk of blood clots, cardiovascular disease, tumors affecting the brain and spine, gallstones, dehydration, and increased urination. Over time, these drugs can also raise the risk of type 2 diabetes, high blood pressure, and osteoporosis in men.
… (content continues)
Source link
